Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 4
2013 1
2014 4
2015 4
2016 2
2017 6
2018 12
2019 8
2020 12
2021 4
2022 5
2023 7
2024 10
2025 23
2026 16

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

104 results

Results by year

Filters applied: . Clear all
Page 1
Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype.
Sciurba FC, Criner GJ, Christenson SA, Martinez FJ, Papi A, Roche N, Bourbeau J, Korn S, Bafadhel M, Han MK, Kolterer S, Miller K, Mouneimne D, Fletcher J, Mayer B, Min J, Pavord ID; MATINEE Study Investigators. Sciurba FC, et al. N Engl J Med. 2025 May 1;392(17):1710-1720. doi: 10.1056/NEJMoa2413181. N Engl J Med. 2025. PMID: 40305712 Clinical Trial.
Biological Biomarkers in Respiratory Diseases.
García-Río F, Alcázar-Navarrete B, Castillo-Villegas D, Cilloniz C, García-Ortega A, Leiro-Fernández V, Lojo-Rodriguez I, Padilla-Galo A, Quezada-Loaiza CA, Rodriguez-Portal JA, Sánchez-de-la-Torre M, Sibila O, Martínez-García MA. García-Río F, et al. Among authors: alcazar navarrete b. Arch Bronconeumol. 2022 Apr;58(4):323-333. doi: 10.1016/j.arbres.2022.01.003. Epub 2022 Jan 17. Arch Bronconeumol. 2022. PMID: 35312522 Free article. Review. English, Spanish.
Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial.
Singh D, Brightling CE, Rabe KF, Han MK, Christenson SA, Drummond MB, Papi A, Pavord ID, Molfino NA, Almqvist G, Kotalik A, Hellqvist Å, Gołąbek M, Sindhwani NS, Ponnarambil SS; COURSE study investigators. Singh D, et al. Lancet Respir Med. 2025 Jan;13(1):47-58. doi: 10.1016/S2213-2600(24)00324-2. Epub 2024 Dec 6. Lancet Respir Med. 2025. PMID: 39653044 Clinical Trial.
Multidisciplinary Management of Patients With Chronic Obstructive Pulmonary Disease and Cardiovascular Disease.
de Miguel-Díez J, Núñez Villota J, Santos Pérez S, Manito Lorite N, Alcázar Navarrete B, Delgado Jiménez JF, Soler-Cataluña JJ, Pascual Figal D, Sobradillo Ecenarro P, Gómez Doblas JJ. de Miguel-Díez J, et al. Among authors: alcazar navarrete b. Arch Bronconeumol. 2024 Apr;60(4):226-237. doi: 10.1016/j.arbres.2024.01.013. Epub 2024 Feb 1. Arch Bronconeumol. 2024. PMID: 38383272 Free article. English, Spanish.
Identification and management of cardiopulmonary risk in patients with chronic obstructive pulmonary disease: a multidisciplinary consensus and modified Delphi study.
Gale CP, Hurst JR, Hawkins NM, Bourbeau J, Han MK, Lam CSP, Marciniuk DD, Price D, Stolz D, Gluckman T, Zieroth S, Nadarajah R, Young RP, Singh D, Martinez FJ, Berg DD, Bhutani M; Global Working Group on Cardiopulmonary Risk. Gale CP, et al. Eur J Prev Cardiol. 2025 Oct 28;32(15):1445-1460. doi: 10.1093/eurjpc/zwaf119. Eur J Prev Cardiol. 2025. PMID: 40037333 Free article.
Mortality risk reduction with budesonide/glycopyrrolate/formoterol fumarate versus fluticasone furoate/umeclidinium/vilanterol in COPD: a matching-adjusted indirect comparison based on ETHOS and IMPACT.
Stolz D, Hermansson E, Ouwens M, Singh B, Sharma A, Jackson D, Darken P, Marshall J, Bowen K, Müllerová H, Alcázar Navarrete B, Russell R, Han MK, Tansey-Dwyer D. Stolz D, et al. Among authors: alcazar navarrete b. Curr Med Res Opin. 2023 Oct;39(10):1395-1405. doi: 10.1080/03007995.2023.2247969. Epub 2023 Aug 29. Curr Med Res Opin. 2023. PMID: 37583267 Free article.
Update 2025 of the Spanish COPD Guidelines (GesEPOC): Pharmacological Treatment of Stable COPD.
Miravitlles M, Calle M, Molina J, Almagro P, Gómez JT, Trigueros JA, Sánchez-Angarita E, Cosío BG, Casanova C, López-Campos JL, Riesco JA, Simonet P, Rigau D, Iskakova A, Pastor Sanz M, Sobradillo P, Alcázar-Navarrete B, Garin N, Soler-Cataluña JJ. Miravitlles M, et al. Among authors: alcazar navarrete b. Arch Bronconeumol. 2025 Dec;61(12):766-782. doi: 10.1016/j.arbres.2025.10.008. Epub 2025 Oct 14. Arch Bronconeumol. 2025. PMID: 41198528 English, Spanish.
104 results